Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for ACUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2002. Start Trial.
Date Value
September 30, 2008 0.012M
June 30, 2008 -0.05M
March 31, 2008 -0.035M
December 31, 2007 -0.248M
September 30, 2007 -0.323M
June 30, 2007 -0.30M
March 31, 2007 -0.122M
December 31, 2006 -0.156M
September 30, 2006 -0.049M
June 30, 2006 -0.715M
March 31, 2006 -0.30M
December 31, 2005 -5.666M
September 30, 2005 -7.51M
June 30, 2005 -13.29M
Date Value
March 31, 2005 -6.404M
December 31, 2004 -5.756M
September 30, 2004 -3.304M
June 30, 2004 -2.456M
March 31, 2004 -0.9243M
December 31, 2003 2.34M
September 30, 2003 1.243M
June 30, 2003 -4.080M
March 31, 2003 0.0384M
December 31, 2002 -0.056M
September 30, 2002 0.851M
June 30, 2002 2.494M
March 31, 2002 5.134M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. -3.054M
Corcept Therapeutics, Inc. -29.24M
Veru, Inc. 1.802M
Johnson & Johnson -1.11B
Eli Lilly & Co. -15.40B